NIKKEI 225
39,038.16 +354.23 (+0.92%) HANG SENG
18,366.95 -109.85 (-0.59%) CRUDE OIL
77.67 +2.14 (+2.83%) GOLD FUTURES
2,327.90 +2.90 (+0.12%) DOW
38,827.50 +28.51 (+0.07%) Bitcoin GBP
54,895.01 +83.43 (+0.15%)
CVS Mar 2025 42.500 call
| Previous close | 18.98 |
| Open | 18.98 |
| Bid | 18.50 |
| Ask | 19.05 |
| Strike | 42.50 |
| Expiry date | 2025-03-21 |
| Day's range | 18.98 - 18.98 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
ZacksIs CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
BenzingaHow To Earn $500 A Month From CVS Health Stock
CVS Health Corporation (NYSE:PVH) shares closed slightly higher during Wednesday's session. On May 30, JPMorgan analyst Lisa Gill maintained CVS Health with an Overweight. She also lowered the price target from $101 to $86. Baird analyst Michael Ha initiated coverage on CVS Health with a Neutral rating and announced a price target of $61. On May 1, CVS Health reported first-quarter sales of $88.4 billion, up 3.7% year over year. It missed the consensus of $89.21 billion. The company also lowered
Zacks2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry
Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.
